Gyre Therapeutics, Inc. Weighted Average Number of Shares Issued, Basic
Gyre Therapeutics, Inc. (GYRE) reported Weighted Average Number of Shares Issued, Basic of 100.64 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesIssuedBasic · last filed 2026-08-07
- Gyre Therapeutics, Inc. weighted average number of shares issued, basic for the quarter ending 2026-06-30 was 100.64M shares, a 12.92% increase year-over-year.
- Gyre Therapeutics, Inc. weighted average number of shares issued, basic for the quarter ending 2026-03-31 was 91.32M shares, a 5.67% increase year-over-year.
- Gyre Therapeutics, Inc. weighted average number of shares issued, basic for the quarter ending 2025-09-30 was 90.85M shares, a 6.08% increase year-over-year.
- Gyre Therapeutics, Inc. weighted average number of shares issued, basic for the quarter ending 2025-06-30 was 89.12M shares, a 4.23% increase year-over-year.
- Gyre Therapeutics, Inc. weighted average number of shares issued, basic for fiscal 2025 was 89.34M shares, a 4.99% increase from fiscal 2024.
- Gyre Therapeutics, Inc. weighted average number of shares issued, basic for fiscal 2024 was 85.09M shares, a 29.26% increase from fiscal 2023.
- Gyre Therapeutics, Inc. weighted average number of shares issued, basic for fiscal 2023 was 65.83M shares, a 3.53% increase from fiscal 2022.
- Gyre Therapeutics, Inc. weighted average number of shares issued, basic for fiscal 2022 was 63.59M shares.
| Period end | Weighted Average Number of Shares Issued, Basic 3 month | Weighted Average Number of Shares Issued, Basic 6 month | Weighted Average Number of Shares Issued, Basic 9 month | Weighted Average Number of Shares Issued, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 100.64M shares 10-Q · filed 2026-08-07 | 96.00M shares 10-Q · filed 2026-08-07 | ||
| 2026-03-31 | 91.32M shares 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | 89.34M shares 10-K · filed 2026-03-13 | |||
| 2025-09-30 | 90.85M shares 10-Q · filed 2025-11-07 | 88.71M shares 10-Q · filed 2025-11-07 | ||
| 2025-06-30 | 89.12M shares 10-Q · filed 2026-08-07 | 87.30M shares 10-Q · filed 2026-08-07 | ||
| 2025-03-31 | 86.42M shares 10-Q · filed 2026-05-08 | |||
| 2024-12-31 | 85.09M shares 10-K · filed 2026-03-13 | |||
| 2024-09-30 | 85.64M shares 10-Q · filed 2025-11-07 | 84.81M shares 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | 85.50M shares 10-Q · filed 2025-08-11 | 84.38M shares 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | 83.27M shares 10-Q · filed 2025-05-09 | |||
| 2023-12-31 | 65.83M shares 10-K · filed 2025-03-17 | |||
| 2023-09-30 | 63.59M shares 10-Q · filed 2024-11-13 | 63.59M shares 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | 63.59M shares 10-Q · filed 2024-08-13 | 63.59M shares 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | 63.59M shares 10-Q · filed 2024-05-13 | |||
| 2022-12-31 | 63.59M shares 10-K · filed 2024-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |